Tratamiento de sangrado postoperatorio en cirugía cardiaca con ...

27. Oliver Warren, MRCS, Kaushik Mandal, MS, MRCS, Vassilis Hadjianastassiou,
MD,Lisa Knowlton, BSc (Hons), Sukhmeet Panesar, BSc. Recombinant Activated
Factor VII in CardiacSurgery: A Systematic Review. Ann Thorac Surg
2007;83:707–14
28. Frumento RJ, O'Malley CM, Bennett-Guerrero E. Stroke after cardiac surgery: a
retrospective analysis of the effect of aprotinin dosing regimens. Ann Thorac Surg
2003; 75(2): 479–483.
29. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future.
Lancet. 2003; 361:161–169.
30. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious
disease markers and estimated window-period risk in the American Red Cross blood
donor population. Transfusion. 2002; 42: 975–979.
31. Busch MP, Glynn SA, Stramer SL et al. A new strategy or estimating risks of
transfusion-transmitted viral infections based on rates of detection of recently
infected donors. Transfusion. 2005; 45: 254–264
32. Levy JH. Anti-inflammatory strategies and hemostatic agents: old drugs, new ideas.
Hematol Oncol Clin North Am. 2007 Feb;21(1):89-101
33. Sauaia A, Moore FA, Moore EE, et al. Multiple organ failure can be predicted as early
as 12 h after injury. J Trauma. 1998; 45: 291–301
34. Baron JF, Gourdin M, Bertrand M et al. The effect of universal leukodepletion of
packed red blood cells on postoperative infections in high-risk patients undergoing
abdominal aortic surgery. Anesth Analg. 2002; 94: 529–537.
35. G. Despotis, M. Renna, C. Eby. Risks associated with bleeding and transfusion:
rationale for the optimal management of bleeding after cardiac surgery. Eur J
Anaesthesiol. 2007; 24(40): 15-36.
48